References
- Lee JC, Kim JS, Lee JH, Nam SY, Choi SH, Lee SW, et al. F-18 FDG-PET as a routine surveillance tool for the detection of recurrent head and neck squamous cell carcinoma. Oral Oncol. 2007 Aug;43(7):686-692. https://doi.org/10.1016/j.oraloncology.2006.08.006
- Rhodes MM, Delbeke D, Whitlock JA, William Mohn, Kuttesch JF, Frangoul HA, et al. Utility of FDG-PET/CT in Follow-Up of Children Treated for Hodgkin and Non-Hodgkin Lymphoma. J Pediatr Hematol Oncol. 2006 May;28(5):300-306. https://doi.org/10.1097/01.mph.0000212912.37512.b1
- Fischbein NJ, AAssar OS, Caputo GR, Kaplan MJ, Singer MI, Price DC, et al. Clinical utility of positron emission tomography with 18F-fluorodeoxyglucose in detecting residual/recurrent squamous cell carcinoma of the head and neck. Am J Neuroradiol. 1998 Aug;19(7):1189-1196.
- Wong RJ, Lin DT, Schoder H, SG Patel, M Gonen, S Woldenet, et al. Diagnostic and prognostic value of [18F]fluorodeoxyglucose positron emission tomography for recurrent head and neck squamous cell carcinoma. J Clin Oncol. 2002 Oct;20(20):4199-4208. https://doi.org/10.1200/JCO.2002.02.590
- Kunkel M, Forster GJ, Reichert TE, JH Jeong, Peter Benz, Peter Bartenstein, et al. Detection of recurrent oral squamous cell carcinoma by [18F]-2-fluorodeoxyglucose-positron emission tomography: implications for prognosis and patient management. Cancer. 2003 Nov;98(15):2257-2265. https://doi.org/10.1002/cncr.11763
- Kitagawa Y, Nishizawa S, Sano K, Ogasawara T, Nakamura M, Sadato N, et al. Prospective comparison of FDG PET with conventional imaging modalities(MRI, CT, and 67Ga scintigraphy) in assessment of combined intraarterial chemotherapy and radiotherapy for head and neck carcinoma. J Nucl Med. 2003 Feb; 44(2):198-206.
- Stokkel MP, Terhaard CH, Hordijk GJ, van Rijk PP. The detection of local recurrent head and neck cancer with fluorine-18 fluorodeoxyglucose dual-head positron emission tomography. Eur J Nucl Med. 1999 Jul;26(7):767-773. https://doi.org/10.1007/s002590050448
- Terhaard CH, Bongers V, van Rijk PP, Hordijk GJ. F-18-fluorodeoxy- glucose positron-emission tomography scanning in detection of local recurrence after radiotherapy for laryngeal/pharyngeal cancer. Head Neck. 2001 Nov;23(11):933-941. https://doi.org/10.1002/hed.1135
- Wong RJ, Lin DT, Schoder H, Patel SG, Gonen M, Wolden S, et al. Diagnostic and prognostic value of 18Ffluorodeoxyglucose positron emission tomography for recurrent head and neck squamous cell carcinoma. J Clin Oncol. 2002 Oct;20(20):4199-4208. https://doi.org/10.1200/JCO.2002.02.590
- Lowe VJ, Boyd JH, Dunphy FR, Han Kim, Dunleavy T, Collins BT, et al. Surveillance for Recurrent Head and Neck Cancer Using Positron Emission Tomography. J Clin Oncol. 2000 Feb;18(3): 615-618.
- Zimny M, Siggelkow W, Schroder W, Nowak B, Biemann S, Rath W, et al. 2-[Fluorine-18]-fluoro-2-deoxy-D-glucose positron emission tomography in the diagnosis of recurrent ovarian cancer. Gynecol Oncol. 2001 Nov;83(2):310-315. https://doi.org/10.1006/gyno.2001.6386
- Ruiz-Hernandez G, Delgado-Bolton RC, Fernandez-Perez C, Lapena- Gutierrez L, Carreras-Delgado JL. Meta-analysis of the diagnostic efficacy of FDG-PET in patients with suspected ovarian cancer recurrence. Rev Esp Med Nucl. 2005 May-Jun;24(3): 161-173. https://doi.org/10.1157/13073787
- Garcia-Velloso MJ, Jurado M, Carolina Ceamanos, Aramendia JM, Garrastachu MP, Guillermo Lopez-Garcia, et al. Diagnostic accuracy of FDG PET in the follow-up of platinum-sensitive epithelial ovarian carcinoma. Euro J Nucl Med Mol Imaging. 2007 Sep;34(9):1396-1405. https://doi.org/10.1007/s00259-007-0366-9